These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
762 related articles for article (PubMed ID: 12750262)
21. Estrogenic effect of soy isoflavones on mammary gland morphogenesis and gene expression profile. Thomsen AR; Almstrup K; Nielsen JE; Sørensen IK; Petersen OW; Leffers H; Breinholt VM Toxicol Sci; 2006 Oct; 93(2):357-68. PubMed ID: 16757570 [TBL] [Abstract][Full Text] [Related]
22. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Ip C; Singh M; Thompson HJ; Scimeca JA Cancer Res; 1994 Mar; 54(5):1212-5. PubMed ID: 8118808 [TBL] [Abstract][Full Text] [Related]
23. The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in Her-2/neu mice. Lanza-Jacoby S; Miller S; Flynn J; Gallatig K; Daskalakis C; Masferrer JL; Zweifel BS; Sembhi H; Russo IH Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1486-91. PubMed ID: 14693742 [TBL] [Abstract][Full Text] [Related]
24. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775 [TBL] [Abstract][Full Text] [Related]
25. Effects of neonatal exposure to diethylstilbestrol, tamoxifen, and toremifene on the BALB/c mouse mammary gland. Hovey RC; Asai-Sato M; Warri A; Terry-Koroma B; Colyn N; Ginsburg E; Vonderhaar BK Biol Reprod; 2005 Feb; 72(2):423-35. PubMed ID: 15470002 [TBL] [Abstract][Full Text] [Related]
26. Tumor-protective and tumor-promoting actions of dietary whey proteins in an N-methyl-N-nitrosourea model of rat mammary carcinogenesis. Eason RR; Till SR; Frank JA; Badger TM; Korourian S; Simmen FA; Simmen RC Nutr Cancer; 2006; 55(2):171-7. PubMed ID: 17044772 [TBL] [Abstract][Full Text] [Related]
27. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis. Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY Cancer Res; 2004 May; 64(10):3525-32. PubMed ID: 15150107 [TBL] [Abstract][Full Text] [Related]
28. [Effect of isoflavones on mammary gland and endometrium of postmenopausal macaques (Macaca fascicularis)]. Foth D; Cline JM; Römer T Zentralbl Gynakol; 2000; 122(2):96-102. PubMed ID: 10721189 [TBL] [Abstract][Full Text] [Related]
29. Effects of soy-derived isoflavones and a high-fat diet on spontaneous mammary tumor development in Tg.NK (MMTV/c-neu) mice. Luijten M; Thomsen AR; van den Berg JA; Wester PW; Verhoef A; Nagelkerke NJ; Adlercreutz H; van Kranen HJ; Piersma AH; Sørensen IK; Rao GN; van Kreijl CF Nutr Cancer; 2004; 50(1):46-54. PubMed ID: 15572297 [TBL] [Abstract][Full Text] [Related]
30. The effect of dietary fat on the rapid development of mammary tumors induced by 7,12-dimethylbenz(a)anthracene in SENCAR mice. Fischer SM; Conti CJ; Locniskar M; Belury MA; Maldve RE; Lee ML; Leyton J; Slaga TJ; Bechtel DH Cancer Res; 1992 Feb; 52(3):662-6. PubMed ID: 1732055 [TBL] [Abstract][Full Text] [Related]
31. Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-alpha female mice. Cleary MP; Jacobson MK; Phillips FC; Getzin SC; Grande JP; Maihle NJ Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):836-43. PubMed ID: 12223427 [TBL] [Abstract][Full Text] [Related]
32. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha. Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494 [TBL] [Abstract][Full Text] [Related]
34. Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice. Rossini A; Rumio C; Sfondrini L; Tagliabue E; Morelli D; Miceli R; Mariani L; Palazzo M; Ménard S; Balsari A Cancer Res; 2006 Jun; 66(12):6219-24. PubMed ID: 16778196 [TBL] [Abstract][Full Text] [Related]
35. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene. Böttinger EP; Jakubczak JL; Haines DC; Bagnall K; Wakefield LM Cancer Res; 1997 Dec; 57(24):5564-70. PubMed ID: 9407968 [TBL] [Abstract][Full Text] [Related]
36. Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musiani P; Cavallo F; Forni G; Nanni P; Lollini PL Am J Pathol; 2005 Apr; 166(4):1205-16. PubMed ID: 15793299 [TBL] [Abstract][Full Text] [Related]
37. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone. Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590 [TBL] [Abstract][Full Text] [Related]
38. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice. Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284 [TBL] [Abstract][Full Text] [Related]
39. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice. Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta. Kang JS; Kim S; Che JH; Nam KT; Kim DJ; Jang DD; Yang KH Oncol Rep; 2004 Oct; 12(4):689-93. PubMed ID: 15375486 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]